Sternal-marrow puncture showed a normal bone marrow, with only a slight increase of basophilic erythroblast ... Thus, each year 1 case of acute leukemia occurred among 20,000 people.

FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...

Obecabtagene autoleucel (obe-cel; Aucatzyl) has been approved by the FDA to treat patients with relapsed or refractory B-cell ...

Partow Kebriaei, MD, discusses when the optimal time for transplant is in patients with acute lymphoblastic leukemia.

Syncona Shs GBP (GB:SYNC) has released an update. Syncona’s portfolio company, Autolus Therapeutics, has received FDA approval for AUCATZYL®, a ...

For children with acute lymphoblastic leukemia (ALL), measurable residual disease (MRD) after the end of first consolidation (EOC) can be used to predict the need for subsequent MRD measurements ...

The FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute ...

Acute anemia can develop due to a rapid drop in red blood cells (RBCs) after losing blood. The more blood a person loses, the more severe the anemia becomes. It usually occurs due to hemorrhage or ...

The technology accurately detects the presence of these gene fusions in acute promyelocytic leukemia ... Radon, Even at Levels Below EPA Guideline for Mitigation, Is Linked to Childhood Leukemia ...

More than one billion people live in acute poverty, with nearly half of them in countries experiencing conflict, according to a new United Nations report. Countries at war have higher levels of ...